New Treatments for epitheliod inflammatory myofibroblastic sarcoma [ 2018 - 2021 ]

Research Grant

Researchers: Dr Karen Mackenzie (Principal investigator) ,  Dr Greg Arndt ,  Dr Toby Trahair

Brief description Epithelioid Inflammatory myofibroblastic sarcoma (eIMS) is a rare aggressive cancer, most common in of childhood and young adults. This cancer has been scarcely studied due to its rarity and is not cured by standard chemotherapeutic regimes. Our investigations will extensively characterise eIMS samples from recently diagnosed patients, and apply a new laboratory model to discover more effective drugs and improve treatment outcomes.

Funding Amount $AUD 656,328.74

Funding Scheme Project Grants

Notes Standard Project Grant